Vanguard Group Inc Vivos Therapeutics, Inc. Transaction History

Vanguard Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.18 - $0.52 $17,836 - $51,527	-99,091 Reduced 13.88%	615,015 $116,000
Q2 2023 Aug 14, 2023	SELL	$0.31 - $0.55 $1,568 - $2,783	-5,061 Reduced 0.7%	714,106 $364,000
Q1 2023 May 15, 2023	SELL	$0.32 - $1.88 $4,056 - $23,829	-12,675 Reduced 1.73%	719,167 $244,000
Q4 2022 Feb 10, 2023	BUY	$0.35 - $20.75 $162 - $9,628	464 Added 0.06%	731,842 $292,000
Q3 2022 Nov 14, 2022	BUY	$0.83 - $21.25 $30,151 - $771,948	36,327 Added 5.23%	731,378 $475,000
Q1 2022 May 13, 2022	BUY	$1.63 - $3.63 $51,830 - $115,426	31,798 Added 4.79%	695,051 $1.86 Million
Q4 2021 Feb 14, 2022	BUY	$2.25 - $4.11 $103,504 - $189,068	46,002 Added 7.45%	663,253 $1.49 Million
Q3 2021 Nov 12, 2021	BUY	$2.71 - $5.9 $632,405 - $1.38 Million	233,360 Added 60.79%	617,251 $2.49 Million
Q2 2021 Aug 13, 2021	BUY	$4.83 - $9.67 $1.85 Million - $3.71 Million	383,891 New	383,891 $1.9 Million

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $60.3M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.